| Literature DB >> 33174530 |
Angel Enrique Roig1,2, Olwyn Mooney2, Alicia Salamanca-Sanabria1,3, Chi Tak Lee2, Simon Farrell2, Derek Richards1,2.
Abstract
BACKGROUND: College students are at elevated risk for developing mental health problems and face specific barriers around accessing evidence-based treatment. Web-based interventions that focus on mental health promotion and strengthening resilience represent one possible solution. Providing support to users has shown to reduce dropout in these interventions. Further research is needed to assess the efficacy and acceptability of these interventions and explore the viability of automating support.Entities:
Keywords: automated support; college students; human support; positive psychology; randomized controlled trial; resilience; web-based intervention; well-being
Year: 2020 PMID: 33174530 PMCID: PMC7688384 DOI: 10.2196/20167
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Measure administration timeline.
| Measure | Measurement point | |
|
| Baseline | Postintervention |
| Sociodemographic and Clinical History Questionnaire | X |
|
| Connor–Davidson Resilience Scale (CD-RISC) | X | X |
| Pemberton Happiness Index (PHI) | X | X |
| Brief Resilience Scale (BRS) | X | X |
| Patient Health Questionnaire—4 Items (PHQ-4) | X | X |
| Rosenberg Self-Esteem Scale (RSES) | X | X |
| Perceived Stress Scale—4 Items (PSS-4) | X | X |
| Satisfaction With Treatment (SAT)a |
| X |
aOnly the active intervention groups completed the SAT.
Figure 1CONSORT flow diagram. ITT: intention to treat. aSome participants met more than 1 reason for exclusion and are categorized as such. bRefers to participants that did not complete postintervention measures. cRefers to participants who did not start the intervention.
Baseline characteristics of study sample.
| Characteristic | Human support (N=29), n (%) | Automated support (N=26), n (%) | Waiting list (N=28), n (%) | Total (N=83), n (%) | |||||
|
|
|
|
|
| |||||
|
| Male | 6 (21) | 4 (15) | 4 (15) | 14 (17) | ||||
|
| Female | 22 (79) | 22 (85) | 23 (85) | 67 (83) | ||||
|
|
|
|
|
| |||||
|
| Undergraduate | 6 (21) | 4 (15) | 0 (0) | 10 (12) | ||||
|
| Postgraduate | 9 (31) | 7 (27) | 13 (48) | 29 (35) | ||||
|
| Other studies | 14 (48) | 15 (58) | 14 (52) | 43 (52) | ||||
|
|
|
|
| ||||||
|
| Very confident | 14 (50) | 15 (58) | 17 (61) | 46 (56) | ||||
|
| Confident | 11 (39) | 9 (35) | 7 (25) | 27 (33) | ||||
|
| Average | 2 (7) | 2 (8) | 3 (11) | 7 (9) | ||||
|
| Mildly confident | 1 (4) | 0 (0) | 1 (4) | 2 (2) | ||||
|
| Not confident | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||||
|
|
|
|
|
| |||||
|
| Human support | 22 (76) | 17 (65) | 16 (57) | 55 (66) | ||||
|
| Automated support | 7 (24) | 9 (35) | 12 (43) | 28 (34) | ||||
Descriptive statistics, effect sizes, and confidence intervals for intention-to-treat and per-protocol analysesa.
| Measure (Construct) | Baseline, mean (SD) | Postintervention, mean (SD) | Within-group effect size, | Between-group effect size, | ||
|
|
|
|
|
| ||
|
|
|
|
|
|
| |
|
|
| HSb | 60.28 (14.02) | 66.63 (11.63) | 0.44 (–0.08 to –0.97) | HS vs AS: 0.02 (–0.51 to 0.55) |
|
|
| ASc | 62.58 (13.50) | 66.43 (11.02) | 0.50 (–0.05 to 1.06) | AS vs WL: –0.14 (–0.68 to 0.39) |
|
|
| WLd | 61.46 (12.63) | 68.17 (12.95) | 0.60 (0.07 to 1.14) | HS vs WL: –0.13 (–0.65 to 0.40) |
|
|
|
|
|
|
| |
|
|
| HS | 6.02 (1.45) | 6.79 (0.99) | 0.46 (–0.07 to –0.98) | HS vs AS: 0.38 (–0.15 to 0.91) |
|
|
| AS | 6.10 (1.59) | 6.41 (1.01) | 0.25 (–0.30 to 0.79) | AS vs WL: –0.46 (–1.00 to 0.08) |
|
|
| WL | 6.68 (1.33) | 6.91 (1.15) | 0.18 (–0.34 to 0.71) | HS vs WL: –0.11 (–0.63 to 0.41) |
|
|
|
|
|
|
| |
|
|
| HS | 3.00 (0.70) | 3.24 (0.54) | 0.57 (–0.05 to 1.10) | HS vs AS: –0.02 (–0.55 to 0.51) |
|
|
| AS | 3.15 (0.69) | 3.25 (0.63) | 0.24 (–0.31 to 0.78) | AS vs WL: 0.09 (–0.44 to 0.63) |
|
|
| WL | 2.98 (0.72) | 3.18 (0.84) | 0.31 (–0.22 to 0.84) | HS vs WL: 0.09 (–0.43 to 0.61) |
|
|
|
|
|
|
| |
|
|
| HS | 4.72 (3.14) | 3.93 (2.58) | –0.23 (–0.75 to 0.28) | HS vs AS: –0.02 (–0.54 to 0.51) |
|
|
| AS | 4.31 (3.22) | 3.89 (2.65) | –0.19 (–0.73 to 0.36) | AS vs WL: –0.38 (–0.92 to 0.16) |
|
|
| WL | 3.61 (2.44) | 2.95 (2.25) | –0.38 (–0.90 to 0.15) | HS vs WL: –0.40 (–0.93 to 0.12) |
|
|
|
|
|
|
| |
|
|
| HS | 26.79 (5.92) | 28.51 (5.27) | 0.53 (0.01 to 1.05) | HS vs AS: 0.04 (–0.49 to 0.57) |
|
|
| AS | 27.27 (5.02) | 28.34 (3.79) | 0.34 (–0.21 to 0.88) | AS vs WL: –0.55 (–1.10 to –0.01) |
|
|
| WL | 29.71 (5.46) | 30.89 (5.27) | 0.37 (–0.16 to 0.90) | HS vs WL: –0.45 (–0.98 to 0.07) |
|
|
|
|
|
|
| |
|
|
| HS | 8.41 (3.52) | 7.36 (2.46) | –0.30 (–0.81 to 0.22) | HS vs AS: –0.08 (–0.61 to 0.45) |
|
|
| AS | 7.31 (2.40) | 7.17 (2.18) | –0.07 (–0.61 to 0.48) | AS vs WL: –0.34 (–0.87 to 0.20) |
|
|
| WL | 6.93 (2.89) | 6.27 (3.06) | –0.42 (–0.95 to 0.11) | HS vs WL: –0.39 (–0.92 to 0.13) |
|
|
|
|
|
| ||
|
|
|
|
|
|
| |
|
|
| HS | 59.40 (15.40) | 63.90 (10.98) | 0.37 (–0.25 to 1.00) | HS vs AS: –0.11 (–0.78 to 0.56) |
|
|
| AS | 63.80 (13.19) | 65.20 (12.21) | 0.20 (–0.52 to 0.92) | AS vs WL: –0.24 (–0.88 to 0.41) |
|
|
| WL | 61.38 (12.39) | 68.29 (13.66) | 0.61 (0.03 to 1.19) | HS vs WL: –0.35 (–0.95 to 0.25) |
|
|
|
|
|
|
| |
|
|
| HS | 6.02 (1.42) | 6.63 (0.96) | 0.45 (–0.18 to 1.08) | HS vs AS: 0.23 (–0.45 to 0.90) |
|
|
| AS | 6.34 (0.96) | 6.39 (1.18) | 0.07 (–0.65 to 0.79) | AS vs WL: –0.42 (–1.07 to 0.23) |
|
|
| WL | 6.64 (1.33) | 6.90 (1.23) | 0.20 (–0.37 to 0.77) | HS vs WL: –0.24 (–0.84 to 0.36) |
|
|
|
|
|
|
| |
|
|
| HS | 2.95 (0.76) | 3.18 (0.63) | 0.50 (–0.13 to 1.13) | HS vs AS: 0.02 (–0.65 to 0.69) |
|
|
| AS | 3.13 (0.78) | 3.17 (0.66) | 0.09 (–0.63 to 0.80) | AS vs WL: 0.04 (–0.61 to 0.68) |
|
|
| WL | 2.92 (0.72) | 3.14 (0.89) | 0.33 (–0.24 to 0.90) | HS vs WL: 0.05 (–0.54 to 0.65) |
|
|
|
|
|
|
| |
|
|
| HS | 4.90 (3.19) | 3.70 (2.27) | –0.39 (–1.01 to 0.24) | HS vs AS: –0.01 (–0.68 to 0.66) |
|
|
| AS | 3.80 (2.91) | 3.67 (2.82) | –0.06 (–0.77 to 0.66) | AS vs WL: –0.28 (–0.93 to 0.37) |
|
|
| WL | 3.71 (2.51) | 2.96 (2.40) | –0.41 (–0.99 to 0.16) | HS vs WL: –0.32 (–0.91 to 0.28) |
|
|
|
|
|
|
| |
|
|
| HS | 26.55 (5.98) | 28.35 (5.69) | 0.49 (–0.14 to 1.12) | HS vs AS: –0.04 (–0.71 to 0.63) |
|
|
| AS | 28.07 (3.95) | 28.53 (3.09) | 0.11 (–0.60 to 0.83) | AS vs WL: –0.48 (–1.13 to 0.17) |
|
|
| WL | 29.46 (5.24) | 30.75 (5.35) | 0.40 (–0.17 to 0.97) | HS vs WL: –0.44 (–1.04 to 0.17) |
|
|
|
|
|
|
| |
|
|
| HS | 9.00 (3.42) | 7.65 (2.60) | –0.33 (–0.95 to 0.30) | HS vs AS: –0.15 (–0.82 to 0.53) |
|
|
| AS | 6.87 (2.33) | 7.27 (2.63) | 0.17 (–0.54 to 0.89) | AS vs WL: –0.31 (–0.96 to 0.34) |
|
|
| WL | 7.13 (2.69) | 6.33 (3.20) | –0.56 (–1.14 to 0.02) | HS vs WL: –0.45 (–1.05 to 0.15) |
aCD-RISC: Connor–Davidson Resilience Scale.
bHS: human support.
cAS: automated support.
dWL: waiting list.
ePHI: Pemberton Happiness Index.
fBRS: Brief Resilience Scale.
gPHQ-4: Patient Health Questionnaire—4-items.
hRSES: Rosenberg Self-Esteem Scale.
iPSS-4: Perceived Stress Scale—4-items.
Descriptive statistics for program engagement and usage.
| Variable | Human support, (N=20), mean (SD) | Automated support, (N=16), mean (SD) | Total, (N=36), mean (SD) | Between-group effect size, |
| Number of sessions | 9.40 (2.93) | 7.38 (4.22) | 8.50 (3.65) | 0.57 (–0.10 to 1.24) |
| Length of program use per session (in minutes) | 20.14 (1.89) | 20.68 (2.45) | 20.38 (8.95) | –0.25 (–0.91 to 0.41) |
| Total length of program use (in minutes) | 197.15 (110.01) | 139.56 (81.72) | 171.55 (101.36) | 0.58 (–0.09 to 1.26) |
| Number of tools used | 8.40 (3.02) | 6.50 (3.86) | 7.56 (3.50) | 0.56 (–0.11 to 1.23) |
| % program content viewed | 48.95 (24.42) | 43.35 (32.08) | 46.46 (27.80) | 0.20 (–0.46 to 0.86) |
| % computer use | 56.94 (37.25) | 73.50 (34.27) | 64.30 (36.42) | –0.46 (–1.13 to 0.21) |
| % mobile use | 40.91 (38.24) | 24.29 (32.32) | 33.52 (36.22) | 0.47 (–0.20 to 1.13) |
| % tablet use | 2.16 (6.74) | 2.21 (8.83) | 2.18 (7.62) | –0.01 (–0.66 to 0.65) |
Descriptive statistics for the SATa.
| Item | Human support, (N=19), mean (SD) | Automated support, (N=15), mean (SD) | Total, (N=34), mean (SD) | Between-group effect size, |
| I was happy to use the computer to access treatmentb | 3.95 (0.85) | 3.67 (0.90) | 3.82 (0.87) | 0.32 (–0.36 to 1.00) |
| I found the online treatment easy to use | 4.16 (0.96) | 4.00 (0.66) | 4.09 (0.83) | 0.19 (–0.49 to 0.87) |
| I felt the treatment received will have a long-lasting effect | 3.26 (0.93) | 3.33 (0.82) | 3.29 (0.87) | –0.08 (–0.76 to 0.60) |
| I would recommend the online treatment to other users | 3.82 (0.77) | 3.40 (0.83) | 3.65 (0.81) | 0.53 (–0.16 to 1.22) |
| Please rate how helpful you found the online treatment programc | 3.05 (0.62) | 2.73 (0.70) | 2.91 (0.67) | 0.49 (–0.20 to 1.17) |
| How likely is it that you would recommend this treatment program to a friend or colleague?d | 6.95 (2.53) | 6.07 (2.66) | 6.56 (2.58) | 0.34 (–0.34 to 1.02) |
aSAT: Satisfaction With Treatment.
bScore range=1-5 for items 1-4.
cScore range=1-4.
dScore range=1-10.